obesity drug news today glp-1 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio The GLP-1 Access Gap: Mapping
Description
Multicenter study
Surgical intervention is typically reserved for fulminant cases or where maximum medical therapy fails
DPP-4 inhibitors and lipids: systematic review and meta-analysis
Bourla said Pfizer acquired a "very good portfolio" from Metsera, and will continue building on its own to become a "formidable competitor" in the space
Nat Med 29 , 29932995 (2023)
Postgrad Med (2015) 127(1):2732
